| Primary |
| Bipolar Ii Disorder |
16.0% |
| Product Used For Unknown Indication |
12.0% |
| Drug Use For Unknown Indication |
10.0% |
| Schizophrenia |
10.0% |
| Agitation |
8.0% |
| Diabetes Mellitus |
6.0% |
| Schizoaffective Disorder |
6.0% |
| Arthritis |
4.0% |
| Depression |
4.0% |
| Hypertension |
4.0% |
| Mental Disorder |
4.0% |
| Mental Retardation |
4.0% |
| Blood Cholesterol Increased |
2.0% |
| Hiccups |
2.0% |
| Insomnia |
2.0% |
| Nervousness |
2.0% |
| Psychotic Disorder |
2.0% |
| Tuberculosis |
2.0% |
|
| Lethargy |
8.0% |
| Psychomotor Skills Impaired |
8.0% |
| Tremor |
8.0% |
| Urinary Incontinence |
8.0% |
| Vomiting |
8.0% |
| Hepatocellular Damage |
4.0% |
| Infection |
4.0% |
| Joint Ankylosis |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Memory Impairment |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Neurotoxicity |
4.0% |
| Neutropenic Sepsis |
4.0% |
| Priapism |
4.0% |
| Rash Erythematous |
4.0% |
| Skin Discolouration |
4.0% |
| Sleep Disorder |
4.0% |
| Somnolence |
4.0% |
| Syncope |
4.0% |
| Tachycardia |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.2% |
| Drug Use For Unknown Indication |
15.7% |
| Schizophrenia |
8.5% |
| Depression |
6.6% |
| Bipolar Disorder |
4.2% |
| Bipolar Ii Disorder |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Hiv Infection |
3.6% |
| Migraine |
3.3% |
| Foetal Exposure During Pregnancy |
3.0% |
| Renal Failure Chronic |
3.0% |
| Parkinsonism |
2.1% |
| Exposure During Breast Feeding |
1.8% |
| Suicidal Ideation |
1.5% |
| Insomnia |
1.2% |
| Vomiting |
1.2% |
| Anxiety |
0.9% |
| Anxiety Disorder |
0.9% |
| Constipation |
0.9% |
| Schizoaffective Disorder |
0.9% |
|
| Toxicity To Various Agents |
13.3% |
| Neurogenic Bladder |
11.1% |
| Suicide Attempt |
8.9% |
| Pre-eclampsia |
6.7% |
| Premature Baby |
6.7% |
| Tremor |
6.7% |
| Completed Suicide |
4.4% |
| Convulsion |
4.4% |
| Electrocardiogram Qt Prolonged |
4.4% |
| Hepatic Failure |
4.4% |
| Overdose |
4.4% |
| Thrombocytopenia |
4.4% |
| Urinary Retention |
4.4% |
| Activities Of Daily Living Impaired |
2.2% |
| Agranulocytosis |
2.2% |
| Cleft Palate |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
| Drug Toxicity |
2.2% |
| Exposure During Pregnancy |
2.2% |
| Faecaloma |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.2% |
| Schizophrenia |
17.2% |
| Drug Use For Unknown Indication |
12.9% |
| Schizophrenia, Paranoid Type |
5.8% |
| Constipation |
5.1% |
| Depression |
4.1% |
| Bipolar Disorder |
3.9% |
| Ill-defined Disorder |
2.9% |
| Prophylaxis |
2.4% |
| Maintenance Of Anaesthesia |
2.2% |
| Nausea |
2.2% |
| Non-small Cell Lung Cancer |
2.2% |
| General Anaesthesia |
1.9% |
| Personality Disorder |
1.9% |
| Hiccups |
1.7% |
| Anaemia |
1.5% |
| Analgesic Therapy |
1.5% |
| Anxiety |
1.5% |
| Arthralgia |
1.5% |
| Back Pain |
1.5% |
|
| Pyrexia |
12.9% |
| Rhabdomyolysis |
11.3% |
| Status Epilepticus |
9.7% |
| Vomiting |
9.7% |
| Drug Interaction |
8.1% |
| Febrile Neutropenia |
4.8% |
| Granulocytopenia |
4.8% |
| Multiple Drug Overdose |
4.8% |
| Parkinsonism |
4.8% |
| Urticaria |
4.8% |
| Androgenetic Alopecia |
3.2% |
| Hypotension |
3.2% |
| Nervousness |
3.2% |
| Pneumonia |
3.2% |
| Thrombocytopenia |
3.2% |
| Agranulocytosis |
1.6% |
| Back Pain |
1.6% |
| Blood Potassium Increased |
1.6% |
| Blood Urea Increased |
1.6% |
| Dehydration |
1.6% |
|
| Interacting |
| Hypoaesthesia |
50.0% |
| Pain In Extremity |
50.0% |
|
|
